Stanczak and co-Workers reported that after recovery from COVID-19, individuals have persisting, circulating peripheral blood mononuclear cells (PBMCs) that produce IL-33 in response to virus-specific T cell activation, which correlates with seropositivity (165). The gene discussed is IL33; the disease is COVID-19.